CA
NZ
UK
AU
IND
US
Skye Bioscience, Inc. filed a Form 8-K on November 12, 2026, reporting that on November 10, 2026, a jury returned a unanimous verdict in favor of the company on all claims in the retrial of Wendy Cunning vs Skye Bioscience, Inc. in the U.S. …
Orion Group Holdings, Inc. filed a Form 8-K on November 12, 2026, reporting the election of Mark Handley to its Board of Directors effective November 11, 2026, along with an expansion of the Board from six to seven members.
CarParts.com, Inc. filed a Form 8-K on November 12, 2026, reporting Board-approved changes to its Nominating and Corporate Governance Committee and Audit Committee, effective November 10, 2026.
BTCS Inc. filed a Form 8-K with the SEC on November 12, 2026, announcing its financial results for the quarter ended September 30, 2026, alongside updated investor materials made available under Regulation FD.
Oncolytics Biotech Inc. filed a current report on November 12, 2026, disclosing a clinical supply agreement announced on November 11, 2026, with Coherus Oncology, Inc. to support a clinical study focused on second-line squamous cell anal carcinoma patients at a premier cancer center in …
SeaStar Medical Holding Corporation filed a Form 8-K on November 12, 2026, reporting that on November 11, 2026, it issued a press release and hosted a webcast covering its financial condition and results of operations for the three and nine months ended September 30, …
Phoenix Education Partners, Inc. filed a Form 8-K on November 12, 2026, disclosing that its Board of Directors declared a special cash dividend of $2.36 per share on November 11, 2026.
PVH Corp. filed an 8-K on November 12, 2026, disclosing the launch of a global enterprise-wide restructuring initiative aimed at simplifying operations, reducing its workforce by approximately 4%, and achieving at least $150 million in annualized net pre-tax cost savings beginning in fiscal 2028.
Cohen & Company Inc. filed a Form 8-K on November 12, 2026, reporting the November 9, 2026 resignation of Chief Executive Officer Lester R. Brafman and the appointment of Executive Chairman Daniel G. Cohen as his successor, effective November 10, 2026.
Hancock Whitney Corporation filed an 8-K on November 12, 2026, disclosing the execution of an Agreement and Plan of Merger with Trustmark Corporation, under which Trustmark will merge with and into Hancock Whitney, with Hancock Whitney continuing as the surviving corporation.
Please wait processing your request...